David Brown

2.5k citations
34 papers · 2.0k · 1 hit paper · h-index 25

Impact in

    • Inflammatory mediators and NSAID effects
    • Antibiotics Pharmacokinetics and Efficacy
    • Antibiotic Resistance in Bacteria

Papers in

David Brown

34 papers receiving 1.9k citations

David Brown's Hit Papers

4-[5-Methyl-3-phenylisoxazol-4-yl]- benzenesulfonamide, Valdecoxib:  A Potent and Selective Inhibitor of COX-2 2000 · 569 citations
5690+8+17Years since publication100200300400500

Peers

David Brown
Comparison fields: 5 of 121
  • Pharmacology 786
  • Molecular Medicine 221
  • Organic Chemistry 803
  • Applied Microbiology and Biotechnology 55
  • Infectious Diseases 279
Replace Silvana Grasso with:
Silvana Grasso Italy
Khalid Islam Italy
John P. O’Donnell United States
Zhe Li China
Éric Marsault Canada
I Hayakawa Japan
G. Garau Italy
Sandra Gemma Italy
Stefania Butini Italy
E. B. Chain United Kingdom
David Brown relative to Silvana Grasso Italy Silvana Grasso's profile →
Citations per field
00.5×3.1×
Silvana Grasso · 1×
Citations per year

Countries citing papers authored by David Brown

Since Specialization
Citations

This map shows the geographic impact of David Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Brown more than expected).

Fields of papers citing papers by David Brown

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Brown. The network helps show where David Brown may publish in the future.

Co-authors

The 25 scholars most cited alongside David Brown, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David Brown Line = papers co-authored together David Brown links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.

#Work
1
4-[5-Methyl-3-phenylisoxazol-4-yl]- benzenesulfonamide, Valdecoxib:  A Potent and Selective Inhibitor of COX-2
Hit paper breakdown →
2000569
2 2000172
3 2007125
4 1989115
5 200678
6 201176
7 201169
8 201168
9 201062
10 201059
11 199553
12
Modafinil's effects on simulator performance and mood in pilots during 37 h without sleep.
200451
13 199746
14 201043
15 198540
16 199740
17 197238
18 201038
19 201033
20 197433

About David Brown

David Brown is a scholar working on Organic Chemistry, Molecular Biology, Pharmacology, Oncology and Epidemiology, having authored 34 papers that have together received 2.0k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (6 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers), Inflammatory mediators and NSAID effects (5 papers), Peptidase Inhibition and Analysis (4 papers), Synthesis of β-Lactam Compounds (3 papers), Pneumonia and Respiratory Infections (3 papers), Carbohydrate Chemistry and Synthesis (3 papers) and Synthesis and biological activity (3 papers). The work is most often cited by research in Pharmacology (786 citations), Molecular Medicine (221 citations), Organic Chemistry (803 citations), Applied Microbiology and Biotechnology (55 citations) and Infectious Diseases (279 citations). David Brown has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include John J. Talley, Karen Seibert, Matthew J. Graneto, Jeffery S. Carter, Carol M. Koboldt, Arnold Louie, George L. Drusano, Jaime L. Masferrer, Ben S. Zweifel and Alexander F. Shaffer. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Canadian Journal of Microbiology and Journal of the American Chemical Society.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact